Pharmacological Management of Attention-Deficit Hyperactivity Disorder in Adolescents: Special Considerations

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.1, 2007-01, pp. : 37-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological management of attention-deficit hyperactivity disorder

By Reeves Gloria Schweitzer Julie

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1313-1320

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management

By Staller Jud Faraone Stephen V.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 107-123

Adis International

Access to resources Recommend Favorite

The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 11, 2007-11 ,pp. : 9-12

Adis International

Access to resources Recommend Favorite

Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Safety Considerations

By Wolraich Mark L. McGuinn Laura Doffing Melissa

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 17-26

Adis International

Access to resources Recommend Favorite